Somnus
ID: 353867Type: Posted
Overview

Buyer

DARPA - Biological Technologies Office (DOD-DARPA-BTO)

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353867

Additional Information

https://sam.gov/opp/be39e28db0fc4514b0c8ed1bbdcf0154/view
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 29, 2024 12:00 AM
  4. 4
    Due Jun 17, 2024 12:00 AM
Description

The federal grant notice titled "Somnus" is being offered by the DARPA - Biological Technologies Office. The grant falls under the category of Science and Technology and other Research and Development. The opportunity is currently open and falls under the discretionary funding category.

The purpose of this grant is to support research on the identification of molecules and mechanisms of host interactions with the gut microbiome that are associated with the restorative effect of sleep on cognitive performance. The DARPA's Biological Technologies Office (BTO) is seeking rapid, targeted, and limited scope investments through this Research Announcement.

The grant does not require cost sharing or matching. It is open to all responsible sources capable of satisfying the government's needs. The eligibility information can be found in the BAA (Broad Agency Announcement) for more details.

The opportunity will close on June 17, 2024. Interested applicants can find additional information and submit proposals through the SAM.gov Contract Opportunities website. For any inquiries, contact Matthew Pava at Somnus@darpa.mil.

Please ensure the summary is centered around the research thrust of "Somnus," which focuses on the identification of molecules and mechanisms associated with the restorative effect of sleep on cognitive performance.

Point(s) of Contact
Somnus@darpa.mil
Similar Opportunities
Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)". This grant aims to support basic science experimental studies that expand our knowledge of the interrelationships between sleep/circadian rhythms and substance use disorders (SUDs). The studies will provide insights into the fundamental processes that link SUDs to disorders of sleep/circadian rhythm and vice-versa. Additionally, these studies may have implications for managing risks associated with developing SUDs and/or identifying new targets for prevention and therapeutics. The grant does not require cost sharing or matching. The funding instrument type is a grant, and the category of funding activity is health. The grant has a closing date of October 29, 2024, and an award ceiling of $200,000. Other eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-045.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-045.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)". This grant aims to support pilot research that focuses on adapting, optimizing, and testing behavioral interventions for common sleep problems in adolescents and young adults with or at risk for a mental health disorder. The pilot trials should evaluate the feasibility, tolerability, acceptability, safety, and potential effectiveness of the interventions in real-world settings. Additionally, the trials should conduct a preliminary test of the interventions' impact on target mechanisms, as well as sleep and mental health outcomes. The grant is particularly interested in studies that address the needs of youth from understudied and underserved populations. The deadline for applications is June 13, 2025. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-130.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-130.html).
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Active
Dept of the Army -- Materiel Command
The Department of the Army -- Materiel Command has posted a federal grant notice titled "DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH". This procurement contract falls under the category of Science and Technology and other Research and Development. The grant notice is currently open for applications and has a closing date of November 20, 2027. The grant is expected to result in 2000 awards. The purpose of this grant is to solicit research proposals for funding consideration by the U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL). The ARL's mission is to Operationalize Science to ensure overmatch in any future conflict. The research mission of ARL includes basic research, applied research, advanced technology development, and advanced component development and prototypes. The grant aims to deliver fundamentally advantageous change rooted in the creation and exploitation of scientific knowledge. Eligible applicants for this grant include institutions of higher education, nonprofit organizations, state and local governments, foreign organizations, foreign public entities, and for-profit organizations (i.e. large and small businesses). The grant announcement provides specific eligibility requirements for ARO Targeted Opportunities and Other Transactions for Prototypes. For more information and to access the list of research topics, interested applicants can visit the ARL BAA topics website at [https://www.arl.army.mil/opportunities/arl-baa/](https://www.arl.army.mil/opportunities/arl-baa/). The point of contact for this grant is the U.S. Army Contracting Command, located at Aberdeen Proving Ground, Research Triangle Park Division, P. O. Box 12211, Research Triangle Park, NC 27709-2211. Overall, this federal grant opportunity aims to support foundational research in order to advance the Army's capabilities and ensure success in future conflicts.
DoD Joint Warfighter Medical, Military Medical Research and Development Award
Active
Dept. of the Army -- USAMRAA
The Department of the Army -- USAMRAA has posted a federal grant opportunity titled "DoD Joint Warfighter Medical, Military Medical Research and Development Award". This procurement contract falls under the category of Science and Technology and other Research and Development. The grant does not require cost sharing or matching. The estimated total program funding for this opportunity is $7,400,000, with an expected number of 3 awards to be granted. The purpose of this grant is to fund the continuation of previously DOD-funded research or development efforts that are relevant to the FY24 JWMRP Focus Areas. The aim is to accelerate and augment the development of medical products and healthcare solutions for active-duty Service Members, their Families, Veterans, and/or the American public. Collaboration with DOD organizations is encouraged, and applications/proposals from small businesses and partnerships with industry are also welcomed. The MMRDA mechanism supports a wide range of research projects, including late-stage preclinical studies, late-stage technology development efforts, technology demonstration, and translational research. Additionally, there is a Clinical Research or Clinical Trial Option available to support clinical research/observational studies, all phases of clinical trials/interventional studies, and correlative studies for the development of promising pharmaceutical or biologic candidates, medical devices, and technologies. Applicants are encouraged to collaborate with DOD organizations when it contributes to the success of the research effort. If any funds are designated for DOD laboratories or activities, they should be identified in the application/proposal through the submission of a "Suggested Intragovernmental/Intramural Budget Form," Attachment 15. Applicants are also required to submit additional relevant application/proposal materials if applying under the Clinical Research or Clinical Trial Option. The close date for this grant opportunity is August 29, 2024, and the archive date is September 28, 2024. For any inquiries or assistance, applicants can contact the CDMRP Help Desk via phone at 301-682-5507 or email at help@eBRAP.org.
Defense Sciences Office (DSO) Office-wide BAA
Active
DARPA - Defense Sciences Office
The Defense Sciences Office (DSO) of the Defense Advanced Research Projects Agency (DARPA) is seeking proposals for a procurement contract. The DSO aims to identify and create the next generation of scientific discovery to fuel innovation within DARPA and beyond. The office focuses on pushing the boundaries of science in order to create strategic surprise advantage for the Department of Defense (DoD). The service/item being procured is research and development (R&D) in various technical areas. The DSO is interested in understanding the direction of commercial R&D and anticipating how adversaries may exploit available technology to develop new capabilities. The procurement contract is open to all responsible sources capable of satisfying the government's needs. The closing date for submitting proposals is September 26, 2024. For more information and to submit a proposal, please visit the SAM.gov Contract Opportunities website.